Literature DB >> 18608516

Early lipoic acid intake protects retina of diabetic mice.

Siv Johnsen-Soriano1, Maria Garcia-Pous, Emma Arnal, Maria Sancho-Tello, Salvador Garcia-Delpech, Maria Miranda, Francisco Bosch-Morell, Manuel Diaz-Llopis, Amparo Navea, Francisco Javier Romero.   

Abstract

The aim of this study was to test the effect of lipoic acid treatment on the retina after a short diabetic insult. Diabetes was induced by alloxan and mice were divided into sub-groups; control, diabetic, diabetic+insulin and all groups received+/-lipoic acid (100 mg/kg body weight) for 3 weeks. GSH content, MDA concentration, GPx activity were measured and electroretinograms (ERG) were recorded. Early administration of lipoic acid to diabetic mice prevented the statistically significant decreases of GSH content and GPx activity and normalized MDA concentration. Moreover, lipoic acid restored electroretinogram b-wave amplitude of diabetic animals to control values. Lipoic acid has a protective effect on the diabetic retina.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608516     DOI: 10.1080/10715760802206791

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  24 in total

1.  Systemic administration of the antioxidant/iron chelator α-lipoic acid protects against light-induced photoreceptor degeneration in the mouse retina.

Authors:  Liangliang Zhao; Chenguang Wang; Delu Song; Yafeng Li; Ying Song; Guanfang Su; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-21       Impact factor: 4.799

2.  Systemic Retinaldehyde Treatment Corrects Retinal Oxidative Stress, Rod Dysfunction, and Impaired Visual Performance in Diabetic Mice.

Authors:  Bruce A Berkowitz; Timothy S Kern; David Bissig; Priya Patel; Ankit Bhatia; Vladimir J Kefalov; Robin Roberts
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

3.  Effects of alpha-lipoic acid on retinal ganglion cells, retinal thicknesses, and VEGF production in an experimental model of diabetes.

Authors:  Emrah Kan; Ömer Alici; Elif Kılıç Kan; Ahmet Ayar
Journal:  Int Ophthalmol       Date:  2016-11-15       Impact factor: 2.031

4.  Oxidative stress and light-evoked responses of the posterior segment in a mouse model of diabetic retinopathy.

Authors:  Bruce A Berkowitz; Edmund Michael Grady; Nikita Khetarpal; Akshar Patel; Robin Roberts
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-08       Impact factor: 4.799

5.  Alpha-lipoic acid induces elevated S-adenosylhomocysteine and depletes S-adenosylmethionine.

Authors:  Sally P Stabler; Jeevan Sekhar; Robert H Allen; Heidi C O'Neill; Carl W White
Journal:  Free Radic Biol Med       Date:  2009-07-17       Impact factor: 7.376

6.  Adverse cardiac responses to alpha-lipoic acid in a rat-diabetic model: possible mechanisms?

Authors:  Nouf M Al-Rasheed; Nawal M Al-Rasheed; Hala A Attia; Iman H Hasan; Maha Al-Amin; Hanaa Al-Ajmi; Raeesa A Mohamad
Journal:  J Physiol Biochem       Date:  2013-04-18       Impact factor: 4.158

7.  Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease.

Authors:  Ivy S Samuels; Chieh-Allen Lee; J Mark Petrash; Neal S Peachey; Timothy S Kern
Journal:  Vis Neurosci       Date:  2012-10-29       Impact factor: 3.241

Review 8.  MRI of rod cell compartment-specific function in disease and treatment in vivo.

Authors:  Bruce A Berkowitz; David Bissig; Robin Roberts
Journal:  Prog Retin Eye Res       Date:  2015-09-04       Impact factor: 21.198

9.  Donor cornea transfer from Optisol GS to organ culture storage: a two-step procedure to increase donor tissue lifespan.

Authors:  Kristiane Haug; Amaya Azqueta; Siv Johnsen-Soriano; Aboulghassem Shahdadfar; Liv K Drolsum; Morten C Moe; Magnus T Røger; Francisco J Romero; Andrew R Collins; Bjørn Nicolaissen
Journal:  Acta Ophthalmol       Date:  2012-03-16       Impact factor: 3.761

Review 10.  Validation of structural and functional lesions of diabetic retinopathy in mice.

Authors:  T S Kern; J Tang; B A Berkowitz
Journal:  Mol Vis       Date:  2010-10-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.